Correct Answer: D. Failure of migration of neural crest cells
Hirschsprung disease (HD) is fundamentally a developmental disorder of the enteric nervous system, not a primary motility or inflammatory condition. The pathogenesis hinges on the failure of neural crest cells to migrate cranio-caudally along the intestinal tract during weeks 5–12 of gestation. Neural crest-derived cells (neuroblasts) normally migrate from the proximal (cervical) gut to the distal rectum, populating the myenteric and submucosal plexuses. When this migration is incomplete or arrested, the distal bowel remains aganglionated — lacking the ganglion cells necessary for coordinated peristalsis. The aganglionated segment (most commonly the rectosigmoid in 80% of Indian cases) cannot relax, creating a functional obstruction. This is why HD presents with enterocolitis, abdominal distension, and failure to pass meconium in neonates. The genetic basis involves mutations in genes regulating neural crest cell migration (RET, GDNF, EDN3, EDNRB), confirming the embryological origin. The loss of ganglion cells is therefore a consequence, not the primary pathogenic mechanism — it results from failed migration. Understanding this distinction is critical: HD is not a myopathy, not inflammation, but a developmental neural migration defect.
Why the other options are wrong
A. Loss of ganglion cells — While aganglionosis is the pathological hallmark of Hirschsprung disease, it is not the primary pathogenic mechanism. Loss of ganglion cells is the result of failed neural crest cell migration, not the cause. This option confuses the histological finding with the embryological defect. NBE tests whether students understand the distinction between pathology (what you see on biopsy) and pathogenesis (how it develops). B. Obstruction by inflammatory stricture — This describes secondary enterocolitis or complications of untreated HD, not the primary pathogenesis. Inflammatory strictures may develop in the transition zone or proximal to the aganglionated segment, but inflammation is a consequence of stasis and bacterial overgrowth, not the initiating defect. This trap conflates acute presentation with underlying embryological failure. C. Visceral myopathy — Hirschsprung disease is a neurogenic disorder, not a myopathy. The smooth muscle itself is structurally and functionally normal; the problem is the absence of innervation (specifically, inhibitory neurons secreting nitric oxide and VIP). Conditions like pseudo-obstruction or megacolon from myopathy present differently. This option tests whether students confuse neurogenic versus myogenic causes of dysmotility.
High-Yield Facts
- Pathogenesis of HD: failure of neural crest cell migration (weeks 5–12 gestation) → aganglionosis → functional obstruction
- RET gene mutations account for ~50% of familial HD; other genes (GDNF, EDN3, EDNRB) regulate neural crest migration
- Rectosigmoid involvement in ~80% of Indian HD cases; total colonic aganglionosis (TCA) in 5–10%
- Aganglionosis = absence of ganglion cells in myenteric and submucosal plexuses; confirmed by rectal suction biopsy (gold standard in India)
- Transition zone: region where aganglionated bowel meets normally innervated bowel; site of functional obstruction
- Enterocolitis risk: highest in first weeks of life; mortality ~30% if untreated; managed with colostomy before definitive pull-through surgery
Mnemonics
NEURAL CREST MIGRATION (5–12 weeks) Neural crest cells migrate Cranio-Caudally from cervical to rectal gut → populate myenteric/submucosal plexuses → failure = aganglionosis. Use this when asked about embryology of HD. HD ≠ Myopathy (Discriminator) Hirschsprung = Neurogenic (missing neurons) | Pseudo-obstruction = Myopathic (bad muscle). Remember: HD has normal muscle, absent nerves; pseudo-obstruction has abnormal muscle. Quick way to rule out option C.
NBE Trap
NBE pairs "loss of ganglion cells" (option A) with Hirschsprung disease to trap students who confuse the pathological finding (aganglionosis on biopsy) with the pathogenic mechanism (failed neural crest migration). Students who memorize "HD = no ganglion cells" without understanding why will pick A instead of D.
Clinical Pearl
In Indian neonatal practice, suction rectal biopsy (non-invasive, bedside-friendly) is the gold standard for confirming HD by demonstrating aganglionosis. A neonate presenting with abdominal distension and failure to pass meconium within 48 hours should raise suspicion; the underlying defect is always the arrested migration of neural crest cells during fetal development, making early surgical referral (colostomy, then definitive pull-through) life-saving.
_Reference: Robbins and Cotran Pathologic Basis of Disease, Ch. 17 (Gastrointestinal Tract); Harrison's Principles of Internal Medicine, Ch. 297 (Gastrointestinal Diseases)_